Pure Global

WERFEN COLOMBIA SAS - Authorized Company ProfileTHROW COLOMBIA SAS

Explore comprehensive authorized company profile for WERFEN COLOMBIA SAS through Pure Global AI's free Colombia medical device database. This company manufactures 145 medical devices registered with INVIMA across 4 risk classes. Their registration history spans from May 09, 2022 to Dec 20, 2031.

This page provides detailed insights including recent registrations, risk class distribution (IIa: 4, II: 132, I: 3, and more), and complete regulatory information from the official Colombia INVIMA medical device database with bilingual Spanish/English support. Pure Global AI offers free access to Colombia's complete medical device registry.

Free Authorized Company Profile
Powered by Pure Global AI
145 Devices
4 Risk Classes
WERFEN COLOMBIA SAS
THROW COLOMBIA SAS
Authorized Company
145
Total Devices
4
Risk Classes
2022
Earliest
2031
Latest
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Recent Registrations
Latest 20 INVIMA device registrations

QUANTA FLASH® CIRCULATING CALPROTECTIN CALIBRATORS

QUANTA FLASH® CIRCULATING CALPROTECTIN CALIBRATORS

dd91962a5133d52994b2c74beed2d850

Dec 20, 2031

QUANTA FLASH® CIRCULATING CALPROTECTIN REAGENTS

QUANTA FLASH® CIRCULATING CALPROTECTIN REAGENTS

a5b24d9d9d2057890adce039a3b07753

II
Dec 20, 2031

QUANTA LITE® ENA 6 ELISA

QUANTA LITE® ENA 6 ELISA

ee80d8fbced80ba0f0d2cb9c7fae75dc

Dec 20, 2031

QUANTA FLASH® CIRCULATING CALPROTECTIN CONTROLS

QUANTA FLASH® CIRCULATING CALPROTECTIN CONTROLS

566185c4da9148bf03324a356fd1feac

Dec 20, 2031

QUANTA-LYSER® 2. - PIPETEADOR ROBÓTICO AUTOMATIZADO PARA IFA/EIA

QUANTA-LYSER® 2. - AUTOMATED ROBOTIC PIPETTE FOR IFA/EIA

894676fba98f039312bd10b09753a3a0

IIa
Nov 22, 2031

HEMOSIL ACUSTAR ANTI-ß2 GLYCOPROTEIN-I IGM CONTROLS

HEMOSIL ACUSTAR ANTI-ß2 GLYCOPROTEIN-I IGM CONTROLS

22d2d308d123835f8f50fbf864e930c1

Sep 16, 2031

HEMOSIL ACUSTAR ANTI-CARDIOLIPIN IGM CONTROLS

HEMOSIL ACUSTAR ANTI-CARDIOLIPIN IGM CONTROLS

7bcea1525f3f30f32ae24b37101d352f

Sep 16, 2031

HEMOSIL ACUSTAR ANTI-CARDIOLIPIN IGG CONTROLS

HEMOSIL ACUSTAR ANTI-CARDIOLIPIN IGG CONTROLS

2e1b7fa8e03c635677837a3ca93f9a3e

II
Sep 16, 2031

HEMOSIL ACUSTAR ANTI-ß2 GLYCOPROTEIN-I IGG CONTROLS

HEMOSIL ACUSTAR ANTI-ß2 GLYCOPROTEIN-I IGG CONTROLS

ea223ec280928a7326a9cfd31d7a5137

Sep 16, 2031

R EXTEM®

R EXTEM®

4fde090388394f5db15bdb9f1533505e

II
Dec 20, 2027

ARA-TEM ®

NOW-TEM ®

b04535c2409e3be16b3178774d450d2d

II
Dec 20, 2027

IN-TEM® S

AND-TO-THE-OTHER®

89fba84b174b28d01357d232435466d5

II
Dec 20, 2027

HEP-TEM® S

HEP-TEM® S

6f9b603db9b788849cfb7f9eeca428bb

II
Dec 20, 2027

TRAP-TEM ®

TRAP-TEM ®

0e0e881230e178e6739f8a268c54fe85

II
Dec 20, 2027

ADP-TEM ®

ADP-TEM ®

938b2922b33b44f5559f1dd997363f1c

II
Dec 20, 2027

FIB-TEM®

FIB-TEM®

29359bd0ebd553e74272ebd17c9a00a0

II
Dec 20, 2027

EXTEM® S

EXTEM® S

9d979373b420760497ab463b2f7b0a10

II
Dec 20, 2027

FIB-TEM® S

FIB-TEM® S

a5d442219a772ff34ebafe8370b98774

II
Dec 20, 2027

IN-TEM®

IN-THE-TO®

d00e6e5cc3189dfcf097c8c59282df32

II
Dec 20, 2027

AP-TEM® S

AP-TEM® S

1da1cb38a90042c435829282902ffc55

II
Dec 20, 2027
Risk Class Distribution
Devices by risk class
II
132
91.0% of total
Unspecified
6
4.1% of total
IIa
4
2.8% of total
I
3
2.1% of total